Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Generic Name: eszopiclone

Summary for Generic Name: eszopiclone

Drug Master File Entries: see list20
Suppliers: see list11
Therapeutic Class:Sedatives/Hypnotics

Clinical Trials for: eszopiclone

Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder
Status: Completed Condition: Post-Traumatic Stress Disorders

The Effects of Eszopiclone and Lexapro on Prefrontal Glutamate and GABA in Depression With Anxiety and Insomnia
Status: Completed Condition: Depression; Anxiety; Insomnia

Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of Eszopiclone
Status: Completed Condition: Parkinson's Disease; Insomnia

Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia
Status: Completed Condition: Insomnia; Attention Deficit Hyperactivity Disorder

Efficacy & Safety of Eszopiclone (Lunesta) in Nursing Home Patients
Status: Completed Condition: Poor Quality Sleep

Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia
Status: Completed Condition: Schizophrenia

Eszopiclone for the Treatment of Posttraumatic Stress Disorder
Status: Recruiting Condition: Posttraumatic Stress Disorders

Eszopiclone in the Treatment of Insomnia and Fibromyalgia
Status: Completed Condition: Fibromyalgia; Insomnia

Hypnotics to Improve Polysomnography Yield: Eszopiclone vs Ramelteon?
Status: Completed Condition: Obstructive Sleep Apnea

Effects of Daytime Eszopiclone Administration in Shift Workers
Status: Completed Condition: Shift-Work Sleep Disorder

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Dr Reddys Labs Ltd
TABLET;ORAL091024Apr 15, 2014RXNo<disabled>
Glenmark Generics
TABLET;ORAL091166Apr 15, 2014RXNo<disabled>
Lupin Ltd
TABLET;ORAL091124Sep 13, 2011RXNo<disabled>
Mylan Pharms Inc
TABLET;ORAL091151Mar 26, 2013RXNo<disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology